Laurel is a highly skilled clinical development and operations professional with over 20 years of experience. She excels in functional area oversight, clinical study/program management, and monitoring/site management. Laurel has a proven track record in leading Phase I to IV clinical trials across a broad range of therapeutic areas, including first-in-human studies, ADME, drug-drug interaction, bioequivalence, QTc, and pharmacokinetic studies. With a strong global perspective, she has successfully managed studies in North America, South America, Europe, and Australia.